YTHDC2 expression has been identified to be associated with prognosis, apoptosis activation and ubiquitin‐mediated proteolysis in Head and Neck squamous cell carcinoma (HNSCC).16 Here, YTHDC2 is linked to head and neck squamous cell carcinoma.